Methylation profiling of cell-free DNA is opening new possibilities for detecting cancer at its earliest, pre-symptomatic stages, offering a potential breakthrough in how and when disease is found.
Improved genomic sequencing techniques are increasing the rigor of the clinical development process and genomic profiling is helping to identify new therapeutic targets as well as biomarkers of treatment response
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.